Australia markets close in 2 hours 32 minutes

ProPhase Labs, Inc. (PRPH)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
5.21-0.03 (-0.57%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
28,715
44,384
122,647
79,042
14,514
Cost of revenue
23,429
28,145
51,993
37,054
9,908
Gross profit
5,286
16,239
70,654
41,988
4,606
Operating expenses
Research development
1,546
1,418
652
520
633
Selling general and administrative
33,797
34,502
34,385
22,493
7,498
Total operating expenses
36,072
37,852
47,059
32,187
8,579
Operating income or loss
-30,786
-21,613
23,595
9,801
-3,973
Interest expense
1,575
1,275
764
1,148
295
Total other income/expenses net
99
10
-76
-3,990
1,892
Income before tax
-32,195
-22,800
22,908
5,305
-2,314
Income tax expense
-8,598
-6,018
4,445
-968
12
Income from continuing operations
-23,597
-16,782
18,463
6,273
-2,326
Net income
-23,597
-16,782
18,463
6,273
-2,125
Net income available to common shareholders
-23,597
-16,782
18,463
6,273
-2,125
Basic EPS
-0.27
-0.98
1.17
0.41
-0.18
Diluted EPS
-0.27
-0.98
1.02
0.40
-0.18
Basic average shares
11,564
17,207
15,845
15,172
11,595
Diluted average shares
11,564
17,207
18,651
18,393
11,595